Characterising the molecular changes that underpin the progression and pathogenesis of cancer.

Our Focus

Through the use of cutting edge technologies, Molecular Oncology (MO) aims to identify genes involved in the development of cancer, quickly and accurately.

MO's researchers combine diverse techniques, ranging from genomics, computational biology, tumour imaging, in vitro and in vivo functional models, to study biological and clinical phenotypes. The proteins produced by these genes may serve as targets for novel chemotherapy drugs and other cancer treatments, or imaging scans. MO uses these combined techniques to validate the role of the novel candidate genes in the development of cancer; with an eye towards translating findings into improved treatment options for cancer patients around the world.

News & Events

Dr. Poul Sorensen appointed as an ambassador of the Technical University of Munich

Congratulations to Dr. Poul Sorensen, a UBC Professor of Pathology and a Distinguished Scientist at BC Cancer, for being appointed as an International Ambassador to the Technical University of Munich (TUM), in Germany. These prestigious Ambassadorships are given by TUM to renowned international researchers that have formally conducted research at TUM, and who have retained particularly close ties to the university.

Research Labs

Recent Publications

Back to top